Merck Stock Quote Today

MRK
 Stock
  

USD 90.59  0.01  0.011%   

Market Performance
0 of 100
Odds Of Distress
Less than 15
Merck is trading at 90.59 as of the 16th of August 2022. This is a -0.01 percent down since the beginning of the trading day. The stock's last reported lowest price was 89.87. Merck has less than a 15 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Merck Company are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of September 2021 and ending today, the 16th of August 2022. Click here to learn more.
CUSIP
589331107
Fiscal Year End
December
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
13th of January 1978
Category
Healthcare
Classification
Health Care
Merck Co., Inc. operates as a healthcare company worldwide. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. Merck operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. The company has 2.53 B outstanding shares of which 20.33 M shares are now shorted by investors with about 1.64 days to cover. More on Merck Company
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Merck Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Merck's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Merck or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Merck Company generated a negative expected return over the last 90 days
Merck Company was previously known as MERCK INC and was traded on New York Stock Exchange under the symbol MRK.
Merck Company has a strong financial position based on the latest SEC filings
Over 75.0% of the company shares are owned by institutional investors
On 8th of July 2022 Merck paid $ 0.69 per share dividend to its current shareholders
Latest headline from www.nasdaq.com: Why Moderna Stock Is Sliding Today - Nasdaq
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Merck's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Merck's managers, analysts, and investors.
Environment Score
Governance Score
Social Score
Older SymbolMRK
ChairmanKenneth Frazier
SEC FilingsMerck Security & Exchange Commission EDGAR Reports
Thematic Ideas
Showing 3 out of 4 themes
Excise Tax ActivitiesAnimal TestingCatholic
Fama & French Classification
Average Analyst Recommendation
Analysts covering Merck report their recommendations after researching Merck's financial statements, talking to executives and customers, or listening in on Merck's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Merck Company. The Merck consensus assessment is calculated by taking the average forecast from all of the analysts covering Merck.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Merck Company based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Merck Company financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
StrongDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares2.5 B2.5 B
Fairly Down
Decreasing
Slightly volatile
Weighted Average Shares DilutedB2.5 B
Fairly Up
Decreasing
Slightly volatile
Net Cash Flow from Operations13.7 B14.1 B
Fairly Down
Increasing
Stable
Total Assets96.4 B105.7 B
Significantly Down
Decreasing
Slightly volatile
Total Liabilities67.8 B67.4 B
Slightly Up
Increasing
Slightly volatile
Current Assets28.7 B30.3 B
Notably Down
Decreasing
Slightly volatile
Current Liabilities24.2 B23.9 B
Fairly Up
Increasing
Slightly volatile
Total Debt32 B33.1 B
Sufficiently Down
Increasing
Slightly volatile
Return on Average Assets0.110.137
Significantly Down
Increasing
Slightly volatile
Gross Margin0.760.72
Notably Up
Increasing
Slightly volatile
Asset Turnover0.530.512
Sufficiently Up
Increasing
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Merck's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Financial Strength
Merck's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Merck's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Merck's bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Merck's outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Merck's financial leverage. It provides some insight into what part of Merck's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Merck's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Merck deploys its capital and how much of that capital is borrowed.
Liquidity
Merck cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 31.79 B in debt with debt to equity (D/E) ratio of 0.78, which is OK given its current industry classification. Merck Company has a current ratio of 1.37, which is typical for the industry and considered as normal. Debt can assist Merck until it has trouble settling it off, either with new capital or with free cash flow. So, Merck's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Merck Company sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Merck to invest in growth at high rates of return. When we think about Merck's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

13.75 Billion
Merck Company (MRK) is traded on New York Stock Exchange in USA. It is located in 126 East Lincoln Avenue, Rahway, NJ 07065, United States and employs 67,000 people. Merck Company was previously known as MERCK INC and was traded on New York Stock Exchange under the symbol MRK. Merck is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with total capitalization of 228.85 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merck's market, we take the total number of its shares issued and multiply it by Merck's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Merck Company runs under Healthcare sector within Drug Manufacturers—General industry. The entity has 2.53 B outstanding shares of which 20.33 M shares are now shorted by investors with about 1.64 days to cover. Merck Company has about 8.93 B in cash with 17.22 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.53.
Check Merck Probability Of Bankruptcy
Ownership
Merck Company maintains a total of two billion five hundred thirty million outstanding shares. The majority of Merck outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Merck Company to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Merck Company. Please pay attention to any change in the institutional holdings of Merck as this could imply that something significant has changed or about to change at the company. Please note that no matter how much assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Merck Ownership Details

Merck Stock Price Odds Analysis

What are Merck's target price odds to finish over the current price? Coming from a normal probability distribution, the odds of Merck jumping above the current price in 90 days from now is about 47.26%. The Merck Company probability density function shows the probability of Merck stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Merck has a beta of 0.4123. This indicates as returns on the market go up, Merck average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Merck Company will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Merck Company is significantly underperforming DOW.
  Odds Below 90.59HorizonTargetOdds Above 90.59
52.35%90 days
 90.59 
47.26%
Based on a normal probability distribution, the odds of Merck to move above the current price in 90 days from now is about 47.26 (This Merck Company probability density function shows the probability of Merck Stock to fall within a particular range of prices over 90 days) .

Merck Historical Income Statement

Merck Company Income Statement is one of the three primary financial statements used for reporting Merck's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Merck Company revenue and expense. Merck Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Merck Income Tax Expense is increasing as compared to previous years. The last year's value of Income Tax Expense was reported at 1.52 Billion View More Fundamentals

Merck Stock Against Markets

Picking the right benchmark for Merck stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Merck stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Merck is critical whether you are bullish or bearish towards Merck Company at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Merck without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Global Correlations Now

   

Global Correlations

Find global opportunities by holding instruments from different markets
All  Next Launch Module

Merck Corporate Directors

Merck corporate directors refer to members of a Merck board of directors. The board of directors generally takes responsibility for the Merck's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Merck's board members must vote for the resolution. The Merck board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Rochelle Lazarus - Independent DirectorProfile
Paul Rothman - Independent DirectorProfile
Mary Coe - Independent DirectorProfile
Patricia Russo - Independent DirectorProfile

Invested in Merck Company?

You need to understand the risk of investing before taking a position in Merck. The danger of trading Merck Company is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Merck is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Merck. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Merck Company is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additionally, see Stocks Correlation. Note that the Merck Company information on this page should be used as a complementary analysis to other Merck's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Merck Stock analysis

When running Merck Company price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Is Merck's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
1.54
Market Capitalization
229.5 B
Quarterly Revenue Growth YOY
0.28
Return On Assets
0.13
Return On Equity
0.43
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine Merck value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.